Article Data

  • Views 495
  • Dowloads 130

Reviews

Open Access

Nerve sparing radical hysterectomy in early stage cervical cancer. Latest developments and review of the literature

  • A. Kavallaris1,2,4
  • D. Zygouris1,*,
  • A. Dafopoulos2
  • I. Kalogiannidis1
  • E. Terzakis3

1Fourth Department of Gynecology and Obstetrics, Aristotle University of Thessaloniki, Thessaloniki , Greece

2Department of Obstetrics and Gynecology, University of Schleswig-Holstein, Luebeck , Germany

3Second Department of Gynecology, St. Savvas Anticancer, Oncological Hospital, Athens , Greece

4Department of Gynecologic Oncology, St. Loukas Hospital, Thessaloniki , Greece

DOI: 10.12892/ejgo2211.2015 Vol.36,Issue 1,February 2015 pp.5-9

Published: 10 February 2015

Abstract

Background: Cervical cancer is the second most common malignancy of the female genital tract worldwide. Radical hysterectomy with pelvic lymphadenectomy exemplifies the treatment of choice for early stage disease, whereas even if it is performed by gynaecologist-oncologist, still has the drawback of significant postoperative morbidity, especially for urinary bladder function. Nerve-sparing radical hysterectomy (NSRH) is a technique in which the neural part of the cardinal ligament which encloses the inferior hypogastric plexus, as well as the bladder branch (distal part of the plexus), remains intact. By this way, the bladder’s innervation is safe and its functional recovery is more rapid. There is sufficient data to support the feasibility of the technique via laparotomy and laparoscopy, as well as the effectiveness related to the postoperative bladder dysfunction compared to conventional radical hysterectomy. On the other hand, the evidence related to survival outcomes is weak and derives from non-randomized trials. However, the low rate of local relapses after NSRH in early stage disease (IA2-IB1) with tumor diameter less than two cm makes the procedure suitable for this group of patients. Conclusion: According to the current evidence NSRH seems to be a suitable technique for gynaecologist-oncologist familiar with the method in early stage cervical cancer. It is a technique which improves significantly postoperative bladder recovery and the patients’ quality of life (QoL), without compromising the oncological standard.

Keywords

Radical hysterectomy; Nerve-sparing; Laparoscopy.

Cite and Share

A. Kavallaris,D. Zygouris,A. Dafopoulos,I. Kalogiannidis,E. Terzakis. Nerve sparing radical hysterectomy in early stage cervical cancer. Latest developments and review of the literature. European Journal of Gynaecological Oncology. 2015. 36(1);5-9.

References

[1] Arbyn M., Autier P., Ferlay J.: “Burden of cervical cancer in the 27 members states of the European Union: estimates for 2004”. Ann. Oncol., 2007, 18, 1423.

[2] Parkin D.M., Pisani P., Ferlay J.: “Estimate of the worldwide incidence of 25 majors cancers in 1990”. Int. J. Cancer, 1999, 80, 827.

[3] Lee Y.N., Wang K.L., Lin C.H., Liu C.H., Wang K.G., Lan C.C.: “Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases”. Gynecol Oncol., 1989, 35, 135.

[4] DiSaia P.J., Creasman W.T.: “Invasive cervical cancer. DiSaia PJ, Creasman WT (ed). Clinical gynaecologic oncology, 5th ed. St Louis: Mosby-Year Book, 1997, 66.

[5] Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P. et al.: “Randomized study of radical surgery versus radiotherapy for Stage IB-IIA cervical cancer”. Lancet, 1997, 350, 535.

[6] Papanikolaou A., Kalogiannidis I., Misailidou D., Goutzioulis M., Stamatopoulos P., Makedos A. et al.: “Result on the treatment of uterine cervix cancer: ten years experience”. Eur. J. Gynecol. Oncol., 2008, 6, 607.

[7] Hatch K.D., Fu Y.S.: “Cervical and Vaginal cancer. Berek JS (ed). Novak’s Gynecology. Williams & Wilkins, Baltimore USA, 1996, 1128.

[8] Meigs V.J.: “Radical hysterectomy with bilateral pelvic lymph node dissections. A report of 100 patients operated on five or more years ago”. Am. J. Obstet. Gynecol., 1951, 62, 854.

[9] Piver M.S., Rutledge F., Smith J.P.: “Five classes of extended hysterectomy for women with cervical cancer”. Obstet Gynecol., 1974, 44, 265.

[10] Querleu D., Morrow C.P.: “Classification of radical hysterectomy”. Lancet Oncol., 2008, 9, 297.

[11] Raspagliesi F., Ditto A., Fontanelli R., Solima E., Hanozet F., Zanaboni et al.: “Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve. Gynecol. Oncol., 2004, 93, 307.

[12] Fujii S., Takakura K., Matsumura N., Higuchi T., Yura S., Mandai M. et al.: “Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy”. Gynecol. Oncol., 2007, 107, 4.

[13] Maas C.P., Trimbos J.B., DeRuiter M.C., van de Velde C.J., Kenter G.G.: “Nerve sparing radical hysterectomy: latest developments and historical perspective. Crit. Rev. Oncol. Hematol., 2003, 48, 271. Review.

[14] Okabayashi H.: “Radical abdominal hysterectomy for cancer of the cervix uteri, modification of the Takayama operation”. Surg. Gynecol. Obstet., 1921, 33, 335.

[15] Okabayashi H. 1952: “Radical operation of cervical cancer”. Tokyo: Kanehara Publishing Co.

[16] Wertheim E.: “The extended abdominal operation for carcinoma uteri (based on 500 operative cases)”. Am. J. Obstet. Dis. Women Child., 1912, 66, 169.

[17] Fujiwara T.: “Surgery for cervical cancer (in Japanese)”. Tokyo: Igakutoshyosyuppan, 1984.

[18] Sakamoto S., Takazawa K.: “An improved radical hysterectomy with fewer urological complications and with no loss of therapeutic results for cervical cancer”. Ballieres Clin Obstet Gynecol., 1988, 2, 953.

[19] Yabuki Y., Asamoto A., Hoshiba T., Nishimoto H.., Kitamura S.: “Dissection of the cardinal ligament in radical hysterectomy for cervical cancer with emphasis on the lateral ligament”. Am. J. Obstet. Gynecol., 1991, 164, 7.

[20] Fujii S.: “Original film of the Okabayashi’s radical hysterectomy by Okabayashi himself in 1932, and two films of the precise anatomy necessary for nerve-sparing Okabayashi’s radical hysterectomy clarified by Shingo Fujii”. Int J Gynecol Cancer, 2008, 18, 383.

[21] Yabuki Y., Asamoto A., Hoshiba T., Nishimoto H., Nishikawa Y., Nakajima T.: “Radical hysterectomy: an anatomic evaluation of parametrial dissection”. Gynecol Oncol., 2000, 77, 155.

[22] Sakuragi N., Todo Y., Kudo M., Yamamoto R., Sato T.: “A systematic nerve-sparing radical hysterectomy technique in invasive cervical cancer for preserving postsurgical bladder function”. Int. J. Gynecol. Cancer, 2005, 15, 389.

[23] Kato K., Suzuka K., Osaki T., Tanaka N.: “Unilateral or bilateral nervesparing radical hysterectomy: a surgical technique to preserve the pelvic autonomic nerves while increasing radicality”. Int. J. Gynecol Cancer, 2007, 17, 1172.

[24] Höckel M., Konerding M.A., Heussel C.P.: “Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy and feasibility study”. Am. J. Obstet. Gynecol., 1998, 178, 971.

[25] Höckel M., Horn L.C., Hentschel B., Hockel S., Naumann G.: “Total mesometrial resection: high resolution nerve-sparing radical hysterectomy based on developmentally defined surgical anatomy”. Int. J. Gynecol. Cancer, 2003, 13, 791.

[26] Trimbos J.B., Maas C.P., Deruiter M.C., Peters A.A., Kenter C.G.: “A nerve sparing radical hysterectomy: guidelines and feasibility in Western patients”. Int. J. Gynecol. Cancer, 2001, 11, 180.

[27] Possover M., Stober S., Plaul K., Schneider A.: “Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III”. Gynecol. Oncol., 2000, 79, 154.

[28] Querleu D., Narducci F., Poulard V., Lacaze S., Occelli B., Leblanc E. et al.: “Modified radical vaginal hysterectomy with or without laparoscopic nerve-sparing dissection: aa comparative study”. Gynecol Oncol., 2002, 85, 154.

[29] Park N.Y., Cho Y.L., Park I.S., Lee Y.S.: “Laparoscopic anatomy of nerve-sparing radical hysterectomy”. Clinical Anatomy, 2010, 23, 186.

[30] Kavallaris A., Hornemann A., Chalvatzas N., Luedders D., Diedrick K., Bohlmann M.K.: “Laparoscopic nerve-sparing radical hysterectomy: description of the technique and patients’ outcomes”. Gynecol. Oncol., 2010, 119, 198.

[31] Seski J.C., Diokno A.C.: “Bladder dysfunction after radical abdominal hysterectomy”. Am. J. Obstet. Gynecol., 1977, 128, 643.

[32] Fishman I.J., Shabsigh R., Kaplan A.L.: “Lower urinary tract dysfunction after radical hysterectomy for carcinoma of cervix”. Urology, 1986, 28, 462.

[33] Kuwabara Y., Suzuki M., Hashimoto M., Furugen Y., Yoshida K., Mitsuhashi N.: “New method to prevent bladder dysfunction after radical hysterectomy for uterine cervical cancer”. J. Obstet. Gynaecol. Res., 2000, 26, 1.

[34] Zapico A, Fuentes P, Grassa A, Arnanz F, Otazua J, López Yagüe A, et al.: “An easier ureteral tunnel approach during laparoscopic-assisted radical vaginal hysterectomy”. Gynecol. Surg., 2005, 2, 211.

[35] Scotti RJ, Bergman A, Bhatia NN, Ostergard DR.: “Urodynamic changes in urethrovesical function after radical hysterectomy”. Obstet. Gynecol., 1986, 68, 111.

[36] Zullo M.A., Manci N., Angioli R., Muzii L., Panici P.B.: “Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review”. Crit. Rev. Oncol. Hematol., 2003, 48, 287.

[37] Raspagliesi F., Ditto A., Fontanelli R., Zanaboni F., Solima E., Spatti G. et al.: “Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions”. Gynecol. Oncol., 2006, 102, 256.

[38] Skret-Magierlo J., Narog M., Kruczek A., Kluza R., Kluz T., Magon T. et al.: “Radical hysterectomy during the transition period from traditional to nerve-sparing technique”. Gynecol. Oncol., 2010, 116, 502.

[39] Cibula D., Velechovska P., Slama J., Fischerova D., Pinkavova I., Pavlista D. et al.: “Late morbidity following nerve-sparing radical hysterectomy”. Gynecol. Oncol., 2010, 116, 506.

[40] Van den Tillaart S., Kenter G.G., Peters A.A.W., Dekker F.W., Gaarenstroom K.N., Fleuren G.J. et al.: “Nerve-sparing radical hysterectomy. Local recurrence rate, feasibility, and safety in cervical cancer patients Stage IA to IIA”. Int. J. Gynecol. Cancer, 2009, 19, 39.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top